ArticleJournal of translational medicine2025
Establishing next-generation reference intervals for pro-gastrin-releasing peptide using a dynamic modeling approach.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerum pro-gastrin-releasing peptide (ProGRP) levels significantly vary with age. However, conventional partitioned reference intervals (RIs) fail to reflect the continuous and subtle physiological changes associated with aging. To address this limitation, we investigated the age- and sex-specific dynamics of ProGRP levels and innovatively developed next-generation RIs for adults and elderly individuals in North China.
methodsA total of 4136 rigorously screened individuals (aged 20-80 years) were analyzed. The effects of age and sex on ProGRP levels were assessed using Mann-Whitney U tests, Spearman's correlation, and Kruskal-Wallis tests. The Harris-Boyd method was used to evaluate the necessity of sex or age partitioning. Age-partitioned RIs were established using a nonparametric method. Next-generation RI models were developed using generalized additive models for location, scale, and shape, with age-related dynamics visualized. The clinical applicability of both RI types was evaluated by comparing upper reference limit flagging rates across age subgroups; rates closer to the theoretical 2.5% were considered indicative of superior RI accuracy.
resultsSex had a minimal and clinically insignificant effect on ProGRP levels. In contrast, age had a significant effect: concentrations remained stable until approximately 40 years of age, followed by progressive increases. The partitioned RIs were defined as 0-52.77 pg/mL (20-49 years) and 0-63.68 pg/mL (≥ 50 years). Next-generation RIs were quantified and visualized. Compared with partitioned RIs, next-generation RIs yielded reference limit flagging rates more closely aligned with the theoretical 2.5% across most age groups and demonstrated significantly greater stability (1.83%-3.74% vs. 1.07%-7.10%).
conclusionsCompared with partitioned RIs, next-generation RIs for ProGRP improve the accuracy of laboratory result interpretation. With advances in laboratory informatics, broader clinical implementation of next-generation RIs is anticipated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.